Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The latest exhibition at the Museum of Natural History traces patterns revealed by genetics, archaeology and demography to tell the dynamic story of Britain’s ever-changing population.

From the arrival of the earliest modern humans over 40,000 years ago to the population of the present day, the history of the people of Britain is one of movement, migration and settlement. 'Settlers' at the Oxford Museum of Natural History charts the cultural and genetic impact of major movements of people in Britain – a rich and exciting history of perpetual arrival and departure. 

Settlers exhibition.jpg

Opening with a showcase of remains from the oldest known  ceremonial burial in Western Europe, the 33,000-year-old ‘Red Lady’ of Paviland (actually a man), 'Settlers'  charts the waves of migration that have shaped Britain since the islands became continuously inhabited at the end of the last Ice Age, around 12,000 years ago.

Settlers is the fifth exhibition in the Museum's Contemporary Science & Society series, and is based around the People of the British Isles research project which was led by the Wellcome Centre for Human Genetics (part of the Nuffield Department of Clinical Medicine). It also draws on research from other departments of the University including Geography and Archaeology. 

Accompanying the exhibition is specially commissioned artwork from contemporary visual artist Ian Kirkpatrick, and an extensive of programme of events. The exhibition will run until Sunday 16 September 2018. 

Find out more 

Image courtesy of Claire Williams

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.